Last updated on November 2018

A Phase 3 clinical study for patients with follicular lymphoma

Brief description of study

This study will compare the safety and effectiveness of PF-05280586 versus rituximab-EU in patients with CD20-positive, low tumor burden follicular lymphoma. The primary hypothesis to be tested in this study is that the effectiveness of PF-05280586, as measured by the Overall Response Rate, is similar to that of rituximab-EU.

Clinical Study Identifier: NCT02213263

Contact Investigators or Research Sites near you

Start Over

Chonbuk National University Hospital
Jeonju-si, Korea, Republic of

Recruitment Status: Closed

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.